Editorial: is pharmacogenetic testing for adverse effects to IBD treatments ready for roll‐out?

Journal article

Peer reviewed

Desmond Chee, James R. Goodhand and Tariq Ahmad

Alimentary pharmacology & therapeutics, Vol.52(6), pp.1076-1077

09/2020

PMID: 33119171

Abstract

LINKED CONTENT This article is linked to Bangma et al paper. To view this article, visit https://doi.org/10.1111/apt.15762

1 Record Views

Title: Editorial: is pharmacogenetic testing for adverse effects to IBD treatments ready for roll‐out?
Creators - without role: Desmond Chee - PharmacoGenetics
James R. Goodhand - PharmacoGenetics
Tariq Ahmad - PharmacoGenetics
Publication Details: Alimentary pharmacology & therapeutics, Vol.52(6), pp.1076-1077
Number of pages: 2
Identifiers: 9925765708331
Academic Unit: Prince Sattam Bin Abdulaziz University
Language: English
Resource Type: Journal article